A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 21.12 CNY -4.91% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Aurisco Pharmaceutical Co Ltd?
Write Note

Gross Margin
Aurisco Pharmaceutical Co Ltd

58.1%
Current
51%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
58.1%
=
Gross Profit
837.2m
/
Revenue
1.4B

Gross Margin Across Competitors

Country CN
Market Cap 8.6B CNY
Gross Margin
58%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 710.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.5B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 202.7B CHF
Gross Margin
73%
Country CH
Market Cap 183.3B CHF
Gross Margin
75%
Country UK
Market Cap 162.4B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Aurisco Pharmaceutical Co Ltd
Glance View

Market Cap
8.6B CNY
Industry
Pharmaceuticals

Aurisco Pharmaceutical Co., Ltd. engages in the development and production of pharmaceutical chemicals. The company is headquartered in Taizhou, Zhejiang and currently employs 1,207 full-time employees. The company went IPO on 2020-09-21. The firm's main products are respiratory, cardiovascular, anti-infective and nervous system drugs, including flumethasone, fluticasone propionate, eplerenone, tenofovir, pregabalin and other APIs and intermediates. The firm distributes its products in domestic market and to overseas markets.

Intrinsic Value
34.48 CNY
Undervaluation 39%
Intrinsic Value
Price
A

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
58.1%
=
Gross Profit
837.2m
/
Revenue
1.4B
What is the Gross Margin of Aurisco Pharmaceutical Co Ltd?

Based on Aurisco Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 58.1%.